Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis

• Status: RECRUITING
• Trial end date: 2026-06-30

Summary

This is a single arm, and open-label phase I study

• Phase: PHASE1

Details

• Lead Sponsor: Jiangsu vcare pharmaceutical technology co., LTD